These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30413251)

  • 1. Cardiovascular Disease in Children and Adolescents With Chronic Kidney Disease.
    Weaver DJ; Mitsnefes M
    Semin Nephrol; 2018 Nov; 38(6):559-569. PubMed ID: 30413251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular complications in children with chronic kidney disease.
    Shroff R; Weaver DJ; Mitsnefes MM
    Nat Rev Nephrol; 2011 Sep; 7(11):642-9. PubMed ID: 21912426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal hypertension and cardiovascular disorder in children with chronic kidney disease.
    Peco-Antić A; Paripović D
    Srp Arh Celok Lek; 2014; 142(1-2):113-7. PubMed ID: 24684043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the Method of Definition on the Prevalence of Left-Ventricular Hypertrophy in Children with Chronic Kidney Disease: Data from the Know-Ped CKD Study.
    Cho H; Choi HJ; Kang HG; Ha IS; Cheong HI; Han KH; Kim SH; Cho MH; Shin JI; Lee JH; Park YS
    Kidney Blood Press Res; 2017; 42(3):406-415. PubMed ID: 28689198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD.
    Navaneethan SD; Roy J; Tao K; Brecklin CS; Chen J; Deo R; Flack JM; Ojo AO; Plappert TJ; Raj DS; Saydain G; Sondheimer JH; Sood R; Steigerwalt SP; Townsend RR; Dweik RA; Rahman M;
    J Am Soc Nephrol; 2016 Mar; 27(3):877-86. PubMed ID: 26386072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric CKD and cardiovascular disease.
    Safder O; Al sharif S; Kari JA
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(3):177-84. PubMed ID: 24720458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What happens to the heart in chronic kidney disease?
    Rutherford E; Mark PB
    J R Coll Physicians Edinb; 2017 Mar; 47(1):76-82. PubMed ID: 28569289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney disease and cardiovascular risk.
    Tonelli M; Pfeffer MA
    Annu Rev Med; 2007; 58():123-39. PubMed ID: 17081079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease in children with chronic kidney disease.
    Mitsnefes MM
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):397-405. PubMed ID: 16198279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mineralocorticoid receptor antagonists on left ventricular mass in chronic kidney disease patients: a systematic review and meta-analysis.
    Lu R; Zhang Y; Zhu X; Fan Z; Zhu S; Cui M; Zhang Y; Tang F
    Int Urol Nephrol; 2016 Sep; 48(9):1499-509. PubMed ID: 27193436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism.
    Mitsnefes MM; Kimball TR; Kartal J; Witt SA; Glascock BJ; Khoury PR; Daniels SR
    J Am Soc Nephrol; 2005 Sep; 16(9):2796-803. PubMed ID: 16049067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive study of cardiovascular risk factors, cardiac function and vascular disease in children with chronic renal failure.
    Rinat C; Becker-Cohen R; Nir A; Feinstein S; Shemesh D; Algur N; Ben Shalom E; Farber B; Frishberg Y
    Nephrol Dial Transplant; 2010 Mar; 25(3):785-93. PubMed ID: 19934091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Of heart and kidney: a complicated love story.
    Gaita D; Mihaescu A; Schiller A
    Eur J Prev Cardiol; 2014 Jul; 21(7):840-6. PubMed ID: 23012690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment.
    Granata A; Clementi A; Virzì GM; Brocca A; de Cal M; Scarfia VR; Zanoli L; Ronco C; Corrao S; Malatino L
    Eur J Intern Med; 2016 May; 30():1-6. PubMed ID: 26961461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatin C and Cardiac Measures in Children and Adolescents With CKD.
    Brady TM; Townsend K; Schneider MF; Cox C; Kimball T; Madueme P; Warady B; Furth S; Mitsnefes M
    Am J Kidney Dis; 2017 Feb; 69(2):247-256. PubMed ID: 27856090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [FGF23 and the heart].
    Ezumba I; Quarles LD; Kovesdy CP
    G Ital Nefrol; 2014; 31(6):. PubMed ID: 25504170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal denervation decreases susceptibility of the heart to ventricular fibrillation in a canine model of chronic kidney disease.
    Tang X; Shi L; Cui X; Yu Y; Qi T; Chen C; Tang X
    Exp Physiol; 2017 Nov; 102(11):1414-1423. PubMed ID: 28833735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Disease Risk in Children With Kidney Disease.
    Sethna CB; Merchant K; Reyes A
    Semin Nephrol; 2018 May; 38(3):298-313. PubMed ID: 29753405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations.
    Law JP; Pickup L; Pavlovic D; Townend JN; Ferro CJ
    J Hum Hypertens; 2023 Jan; 37(1):1-19. PubMed ID: 36138105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.